Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis.

Stem Cell Res

JRG Translational Hematology of Congenital Diseases, Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany; REBIRTH-Cluster of Excellence, Hannover Medical School, 30625 Hannover, Germany. Electronic address:

Published: March 2020

Chronic mucocutaneous candidiasis (CMC) is a disease that is characterized by susceptibility to chronic or recurrent infections with Candida spp. due to mutations affecting mainly the IL-17 signaling of T-Cells. The most common etiologies of CMC are gain-of-function (GOF) mutations in the STAT1 gene. In this paper we report the generation of a hiPSC line from a patient suffering from CMC due to a heterozygous GOF STAT1 p.R274Q mutation which can be used for disease modeling purposes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2020.101713DOI Listing

Publication Analysis

Top Keywords

patient suffering
8
chronic mucocutaneous
8
mucocutaneous candidiasis
8
human stat1
4
stat1 gain-of-function
4
gain-of-function ipsc
4
ipsc patient
4
suffering chronic
4
candidiasis chronic
4
candidiasis cmc
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!